Weight-loss drugs linked to rare vision loss: Harvard study [4nS3LLC6L]

Weight-loss drugs linked to rare vision loss: Harvard study [4nS3LLC6L]

Novo Nordisk (NVO) and Eli Lilly (LLY) shares dip in reaction to a Harvard study that found GLP-1 weight-loss drugs Ozempic and Wegovy could be linked to rare cases of vision loss. Yahoo Finance health reporter Anjalee Khemlani explains the study's findings. About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. - Get the latest news and data at finance.yahoo.com - Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO) - Follow Yahoo Finance on social: X: http://twitter.com/YahooFinance Instagram: https://www.instagram.com/yahoofinance/?hl=en TikTok: https://www.tiktok.com/@yahoofinance?lang=en Facebook: https://www.facebook.com/yahoofinance/ LinkedIn: https://www.linkedin.com/company/yahoo-finance #weightloss #yahoofinance #glp1

Related Videos :

• How Rob Kardashian's Life Has 'Completely Changed' Since Weight Loss (Exclusive) [8MoFogS9x]
• Metformin 💊 #shorts #pharmacy #medicine #nursing #pharmacology #fyp [5hhSDH1uv]
• How much berberine should I take? #berberine [20h4JSJ7q]
• Alistair Overeem Workout in Dubai [uUGSWJdPj]
• Mindy Kaling about her kiss with Lee Pace (Conan Show) [Lxj1ljXzM]